NCT02312180View on ClinicalTrials.gov

A Phase 1 Study of ProMetic Plasminogen (Human) Intravenous in Adults and Children With Plasminogen Deficiency

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

February 29, 2016

Conditions
Type I Plasminogen DeficiencyHypoplasminogenemia
Interventions
BIOLOGICAL

Plasminogen (Human) Intravenous

Plasma-derived purified plasminogen formulated for intravenous administration

Trial Locations (1)

46260

Indiana Hemophilia and Thrombosis Center, Indianapolis

All Listed Sponsors
lead

Prometic Biotherapeutics, Inc.

INDUSTRY

NCT02312180 - A Phase 1 Study of ProMetic Plasminogen (Human) Intravenous in Adults and Children With Plasminogen Deficiency | Biotech Hunter | Biotech Hunter